The impact of KRAS mutations on prognosis in surgically resected colorectal cancer patients with liver and lung metastases: a retrospective analysis-Reference-Cited by-同舟云学术

The impact of KRAS mutations on prognosis in surgically resected colorectal cancer patients with liver and lung metastases: a retrospective analysis

Published:2016-02-18 Issue:1 Volume:16 Page:
ISSN:1471-2407
Container-title:BMC Cancer
language:en
Short-container-title:BMC Cancer

Author:

Kim Hae Su,Heo Jin Seok,Lee Jeeyun,Lee Ji Yun,Lee Min-Young,Lim Sung Hee,Lee Woo Yong,Kim Seok Hyung,Park Yoon Ah,Cho Yong Beom,Yun Seong Hyeon,Kim Seung Tae,Park Joon Oh,Lim Ho Yeong,Choi Yong Soo,Kwon Woo Il,Kim Hee Cheol,Park Young Suk

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Link

http://link.springer.com/content/pdf/10.1186/s12885-016-2141-4.pdf

Reference24 articles.

1. Siegel R, Ward E, Brawley O, Jemal A. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin. 2011;61:212–36.

2. Karapetis CS, Khambata-Ford S, Jonker DJ, O’Callaghan CJ, Tu D, Tebbutt NC, et al. K-ras mutations and benefit from cetuximab in advanced colorectal cancer. N Engl J Med. 2008;359:1757–65.

3. Hurwitz H, Fehrenbacher L, Novotny W, Cartwright T, Hainsworth J, Heim W, et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med. 2004;350:2335–42.

4. Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, et al. Genetic alterations during colorectal-tumor development. N Engl J Med. 1988;319:525–32.

5. Van Cutsem E, Kohne CH, Hitre E, Zaluski J, Chang Chien CR, Makhson A, et al. Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer. N Engl J Med. 2009;360:1408–17.

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Case-control study: Unveiling human polyomaviruses and papillomavirus in Egyptian colorectal cancer patients;PLOS ONE;2024-06-11

2. RAS Mutations Predict Recurrence-Free Survival and Recurrence Patterns in Colon Cancer: A Unicenter Study in Morocco;Cancer Control;2024-01

3. Metabolic factors associated with the prognosis of oligometastatic patients treated with stereotactic body radiotherapy;Cancer and Metastasis Reviews;2023-06-01

4. Coinfection of HPVs Is Associated with Advanced Stage in Colorectal Cancer Patients from Qatar;Pathogens;2023-03-08

5. Middle East and North Africa Registry to Characterize Rate of RAS Testing Status in Newly Diagnosed Patients with Metastatic Colorectal Cancer;The Turkish Journal of Gastroenterology;2023-02-23